STOCK TITAN

Wellington discloses sub‑5% Glaukos (GKOS) stake in amended 13G

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Wellington Management Group and related entities filed an amended Schedule 13G reporting their holdings in Glaukos Corporation common stock. The Wellington reporting entities collectively report beneficial ownership of 486,824 shares, with no sole voting or dispositive power and all authority shared across entities and clients.

The filing states this represents ownership of five percent or less of Glaukos’ outstanding common stock and that the securities are owned of record by clients of Wellington-managed investment advisers. Wellington certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of Glaukos.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Wellington Management Group LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:02/10/2026
Wellington Group Holdings LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:02/10/2026
Wellington Investment Advisors Holdings LLP
Signature:Taisia Lowe
Name/Title:Regulatory Analyst
Date:02/10/2026

FAQ

What does Wellington’s Schedule 13G/A filing for Glaukos (GKOS) report?

The filing reports that Wellington Management Group and related entities beneficially own 486,824 Glaukos common shares. These shares are held for clients of Wellington investment advisers and are reported as five percent or less of the company’s outstanding common stock.

How many Glaukos (GKOS) shares does Wellington report beneficially owning?

Wellington reports beneficial ownership of 486,824 Glaukos common shares. The filing notes zero sole voting or dispositive power, with all voting and dispositive authority shared among Wellington entities and their advised clients, consistent with an institutional asset management structure.

Is Wellington’s ownership in Glaukos (GKOS) above the 5% threshold?

No, Wellington’s filing explicitly states ownership of five percent or less of Glaukos’ common stock. Item 5 confirms this sub‑5% status, which typically shifts reporting to a more passive Schedule 13G framework rather than a control‑oriented Schedule 13D.

Who actually holds the Glaukos (GKOS) shares reported by Wellington?

The filing explains that the securities are owned of record by clients of one or more Wellington investment advisers. Those clients have the right to receive dividends and sale proceeds, while Wellington reports beneficial ownership through its advisory and control relationships.

What voting and dispositive powers does Wellington report over Glaukos (GKOS) shares?

Wellington reports no sole voting or dispositive power over Glaukos shares. Instead, it lists shared voting power over 439,613 shares and shared dispositive power over 486,824 shares, reflecting coordinated authority exercised across Wellington-affiliated advisory entities on behalf of their clients.

Does Wellington intend to influence control of Glaukos (GKOS) with this stake?

The certification states the Glaukos securities were acquired and are held in the ordinary course of business. Wellington affirms they were not acquired and are not held for changing or influencing control of Glaukos, aligning with passive institutional investment activity.
Glaukos Corp

NYSE:GKOS

View GKOS Stock Overview

GKOS Rankings

GKOS Latest News

GKOS Latest SEC Filings

GKOS Stock Data

6.26B
55.90M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALISO VIEJO